Neurobiology of Disease (Oct 2009)

Interactions between neuroactive steroids and reelin haploinsufficiency in Purkinje cell survival

  • Filippo Biamonte,
  • Giovanni Assenza,
  • Ramona Marino,
  • Marcello D'Amelio,
  • Roger Panteri,
  • Donatella Caruso,
  • Samuele Scurati,
  • Josue Garcia Yague,
  • Luis Miguel Garcia-Segura,
  • Roberta Cesa,
  • Piergiorgio Strata,
  • Roberto Cosimo Melcangi,
  • Flavio Keller

Journal volume & issue
Vol. 36, no. 1
pp. 103 – 115

Abstract

Read online

We determined total Purkinje cell (PC) numbers in cerebella of wild-type (+/+) and heterozygous (rl/+) reeler mice of either sex during early postnatal development; in parallel, we quantified levels of neuroactive steroids in the cerebellum with mass spectrometry. We also quantified reelin mRNA and protein expression with RT-PCR and Western blotting. PC numbers are selectively reduced at postnatal day 15 (P15) in rl/+ males in comparison to +/+ males, +/+ females, and rl/+ females. Administration of 17β-estradiol (17β-E) into the cisterna magna at P5 increases PC numbers in rl/+ males, but not in the other groups; conversely, estrogen antagonists 4-OH-tamoxifen or ICI 182,780 reduce PC numbers in +/+ and rl/+ females, but have no effect in males. Testosterone (T) levels at P5 are much higher in males than in females, reflecting the perinatal testosterone surge in males. In addition, rl/+ male cerebella at P5 show a peculiar hormonal profile in comparison with the other groups, consisting of increased levels of T and 17β-E, and decreased levels of dihydrotestosterone. RT-PCR analysis indicated that heterozygosity leads to a 50% reduction of reelin mRNA in the cerebellum in both sexes, as expected, and that 17β-E upregulates reelin mRNA, particularly in rl/+ males; reelin mRNA upregulation is associated with an increase of all major reelin isoforms. These effects may represent a novel model of how reelin deficiency interacts with variable perinatal levels of neuroactive steroids, leading to gender-dependent differences in genetic vulnerability.

Keywords